限制性慢性肺同种异体移植物功能障碍的放射学分布模式:对所有表型生存的影响

Taiki Fukuda MD, PhD , Yusei Nakamura MD , Shu-Chi Tseng MD , Yuki Ko MD, PhD , Staci M. Gagne MD , Takeshi Johkoh MD, PhD , Yi Li PhD , David C. Christiani MD, MPH, MS , Hiroya Ojiri MD, PhD , Lynette Sholl MD , Mizuki Nishino MD, MPH , Hiroto Hatabu MD, PhD
{"title":"限制性慢性肺同种异体移植物功能障碍的放射学分布模式:对所有表型生存的影响","authors":"Taiki Fukuda MD, PhD ,&nbsp;Yusei Nakamura MD ,&nbsp;Shu-Chi Tseng MD ,&nbsp;Yuki Ko MD, PhD ,&nbsp;Staci M. Gagne MD ,&nbsp;Takeshi Johkoh MD, PhD ,&nbsp;Yi Li PhD ,&nbsp;David C. Christiani MD, MPH, MS ,&nbsp;Hiroya Ojiri MD, PhD ,&nbsp;Lynette Sholl MD ,&nbsp;Mizuki Nishino MD, MPH ,&nbsp;Hiroto Hatabu MD, PhD","doi":"10.1016/j.jhlto.2025.100232","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Restrictive chronic lung allograft dysfunction (CLAD) demonstrates poor outcomes after lung transplantation. However, the impact of radiological patterns on survival within a restrictive CLAD under the new International Society for Heart and Lung Transplantation (ISHLT) criteria remains unclear.</div></div><div><h3>Methods</h3><div>We analyzed retrospectively 241 bilateral lung transplant recipients between 2005 and 2021. CLAD was diagnosed and classified per the 2019 ISHLT criteria. Restrictive phenotype included restrictive allograft syndrome (RAS) and mixed phenotype. In these cases, RAS-like opacities (RLOs) were evaluated both qualitatively and semiquantitatively on computed tomography at CLAD diagnosis. RLOs were classified into upper-predominant and diffuse/lower-predominant distribution groups. Overall survival after CLAD diagnosis was assessed using Kaplan-Meier method with log-rank test and Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Eighty-three patients were diagnosed with CLAD after transplantation. Twenty-one (25.3%) had restrictive phenotype, which showed shorter survival compared to bronchiolitis obliterans syndrome (median survival: 19.8 vs 68.1 months; hazard ratio [HR], 4.53; 95% confidence interval [CI], 1.96-10.49; <em>p</em> &lt; 0.001). Within the restrictive phenotype, the upper-predominant group demonstrated longer survival than the diffuse/lower-predominant group (median survival: 61.1 vs 15.5 months; <em>p</em> = 0.008). The diffuse/lower-predominant group had shorter survival compared to any other CLAD phenotype (HR, 8.45; 95% CI, 3.40-21.04; <em>p</em> &lt; 0.001). The extent of RLOs within each distribution pattern was not significantly associated with survival.</div></div><div><h3>Conclusions</h3><div>In restrictive phenotype CLAD, RLO distribution patterns determined survival outcomes, with diffuse/lower-predominant showing the poorest prognosis, while the extent of RLOs within each pattern did not correlate with prognosis.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"8 ","pages":"Article 100232"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes\",\"authors\":\"Taiki Fukuda MD, PhD ,&nbsp;Yusei Nakamura MD ,&nbsp;Shu-Chi Tseng MD ,&nbsp;Yuki Ko MD, PhD ,&nbsp;Staci M. Gagne MD ,&nbsp;Takeshi Johkoh MD, PhD ,&nbsp;Yi Li PhD ,&nbsp;David C. Christiani MD, MPH, MS ,&nbsp;Hiroya Ojiri MD, PhD ,&nbsp;Lynette Sholl MD ,&nbsp;Mizuki Nishino MD, MPH ,&nbsp;Hiroto Hatabu MD, PhD\",\"doi\":\"10.1016/j.jhlto.2025.100232\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Restrictive chronic lung allograft dysfunction (CLAD) demonstrates poor outcomes after lung transplantation. However, the impact of radiological patterns on survival within a restrictive CLAD under the new International Society for Heart and Lung Transplantation (ISHLT) criteria remains unclear.</div></div><div><h3>Methods</h3><div>We analyzed retrospectively 241 bilateral lung transplant recipients between 2005 and 2021. CLAD was diagnosed and classified per the 2019 ISHLT criteria. Restrictive phenotype included restrictive allograft syndrome (RAS) and mixed phenotype. In these cases, RAS-like opacities (RLOs) were evaluated both qualitatively and semiquantitatively on computed tomography at CLAD diagnosis. RLOs were classified into upper-predominant and diffuse/lower-predominant distribution groups. Overall survival after CLAD diagnosis was assessed using Kaplan-Meier method with log-rank test and Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Eighty-three patients were diagnosed with CLAD after transplantation. Twenty-one (25.3%) had restrictive phenotype, which showed shorter survival compared to bronchiolitis obliterans syndrome (median survival: 19.8 vs 68.1 months; hazard ratio [HR], 4.53; 95% confidence interval [CI], 1.96-10.49; <em>p</em> &lt; 0.001). Within the restrictive phenotype, the upper-predominant group demonstrated longer survival than the diffuse/lower-predominant group (median survival: 61.1 vs 15.5 months; <em>p</em> = 0.008). The diffuse/lower-predominant group had shorter survival compared to any other CLAD phenotype (HR, 8.45; 95% CI, 3.40-21.04; <em>p</em> &lt; 0.001). The extent of RLOs within each distribution pattern was not significantly associated with survival.</div></div><div><h3>Conclusions</h3><div>In restrictive phenotype CLAD, RLO distribution patterns determined survival outcomes, with diffuse/lower-predominant showing the poorest prognosis, while the extent of RLOs within each pattern did not correlate with prognosis.</div></div>\",\"PeriodicalId\":100741,\"journal\":{\"name\":\"JHLT Open\",\"volume\":\"8 \",\"pages\":\"Article 100232\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHLT Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950133425000278\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133425000278","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

限制性慢性肺同种异体移植物功能障碍(chronic lung allograft dysfunction, CLAD)表明肺移植后预后不良。然而,在新的国际心肺移植学会(ISHLT)标准下,放射学模式对限制性CLAD患者生存的影响尚不清楚。方法回顾性分析2005年至2021年间241例双侧肺移植受者。根据2019年的ISHLT标准诊断和分类CLAD。限制性表型包括限制性同种异体移植综合征(RAS)和混合型。在这些病例中,在计算机断层扫描上定性和半定量地评估ras样混浊(RLOs)。RLOs分为上优势分布组和弥漫性/低优势分布组。采用Kaplan-Meier法、log-rank检验和Cox比例风险模型评估CLAD诊断后的总生存率。结果83例患者移植后诊断为包膜覆层。21例(25.3%)有限制性表型,与闭塞性细支气管炎综合征相比,其生存期较短(中位生存期:19.8个月vs 68.1个月;风险比[HR], 4.53;95%置信区间[CI], 1.96-10.49;p & lt;0.001)。在限制性表型中,高优势组的生存期长于弥漫性/低优势组(中位生存期:61.1个月vs 15.5个月;p = 0.008)。弥漫性/低显性组与其他任何一种表型的CLAD相比生存时间较短(HR, 8.45;95% ci, 3.40-21.04;p & lt;0.001)。在每个分布模式中,RLOs的程度与存活率没有显著相关。结论在限制性表型CLAD中,RLO分布模式决定了生存结果,弥漫性/低显性RLO分布模式预后最差,而每种RLO分布模式的范围与预后无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes

Background

Restrictive chronic lung allograft dysfunction (CLAD) demonstrates poor outcomes after lung transplantation. However, the impact of radiological patterns on survival within a restrictive CLAD under the new International Society for Heart and Lung Transplantation (ISHLT) criteria remains unclear.

Methods

We analyzed retrospectively 241 bilateral lung transplant recipients between 2005 and 2021. CLAD was diagnosed and classified per the 2019 ISHLT criteria. Restrictive phenotype included restrictive allograft syndrome (RAS) and mixed phenotype. In these cases, RAS-like opacities (RLOs) were evaluated both qualitatively and semiquantitatively on computed tomography at CLAD diagnosis. RLOs were classified into upper-predominant and diffuse/lower-predominant distribution groups. Overall survival after CLAD diagnosis was assessed using Kaplan-Meier method with log-rank test and Cox proportional hazards models.

Results

Eighty-three patients were diagnosed with CLAD after transplantation. Twenty-one (25.3%) had restrictive phenotype, which showed shorter survival compared to bronchiolitis obliterans syndrome (median survival: 19.8 vs 68.1 months; hazard ratio [HR], 4.53; 95% confidence interval [CI], 1.96-10.49; p < 0.001). Within the restrictive phenotype, the upper-predominant group demonstrated longer survival than the diffuse/lower-predominant group (median survival: 61.1 vs 15.5 months; p = 0.008). The diffuse/lower-predominant group had shorter survival compared to any other CLAD phenotype (HR, 8.45; 95% CI, 3.40-21.04; p < 0.001). The extent of RLOs within each distribution pattern was not significantly associated with survival.

Conclusions

In restrictive phenotype CLAD, RLO distribution patterns determined survival outcomes, with diffuse/lower-predominant showing the poorest prognosis, while the extent of RLOs within each pattern did not correlate with prognosis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信